SR
Sailesh Raj BhanLead
Since Apr 2005
AUM managed
₹1,19,910.36Cr
Tenure
Since Apr 2005
Funds
3
Nippon India Pharma Gr
Sector - HealthcareNippon India Mutual Fund
NAV
₹538.68
+0.01% today
AUM
₹9,479.08 Cr
Fund size
Expense
1.85%
Regular plan
Min SIP
₹100
per month
Min Lumpsum
₹5,000
one-time
Exit Load
1.0
on redemption
Fund snapshot
Category rank#8 of 10
Risk-o-meterVery High Risk
BenchmarkBSE Healthcare TR INR (100%)
Number of holdings36
Inception05 Jun 2004
Exit load1.0
Risk metrics
Alpha-1.65
Beta0.88
Sharpe ratio0.83
Standard deviation14.76%
Sortino ratio1.36
Capital gains tax
Equity
STCG · short-term
20%Short-term gains taxed at 20%
Applies when equity fund units are sold within 12 months.
LTCG · long-term
12.5%Long-term gains taxed at 12.5%
Applies when equity fund units are sold after 12 months.
Equity-oriented mutual fund taxation applies based on holding period.
Fund managers
KD
Since May 2018
AUM managed
₹5,07,165.07Cr
Tenure
Since May 2018
Funds
51
AS
Since Mar 2026
AUM managed
₹5,11,102.28Cr
Tenure
Since Mar 2026
Funds
47
DS
Since Sep 2025
AUM managed
₹5,15,458.56Cr
Tenure
Since Sep 2025
Funds
50
LM
Since Sep 2025
AUM managed
₹5,15,458.56Cr
Tenure
Since Sep 2025
Funds
50
About Nippon India Pharma Gr
Nippon India Pharma Gr is an open-ended Sector - Healthcare mutual fund scheme offered by Nippon India Mutual Fund under the regular plan with the growth option. Its latest net asset value (NAV) is ₹538.68 per unit and the scheme manages ₹9,479.08 Cr in assets under management. The fund charges an expense ratio of 1.85% and is benchmarked against BSE Healthcare TR INR (100%). Over the trailing 5 years, Nippon India Pharma Gr has delivered +11.56% returns. SEBI's riskometer places this scheme in the Very High Risk category, so read the scheme information document before investing.
Investment objective
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Regular Plan · Growth option · NAV as of 15 Oct 2026
Nippon India Pharma Gr returns
| Period | Fund | Category average |
|---|---|---|
| 1 month | -4.11% | -5.83% |
| 3 months | -4.84% | -3.41% |
| 6 months | +6.92% | +13.35% |
| 1 year | +5.59% | +10.74% |
| 3 years | +15.41% | +19.18% |
| 5 years | +11.56% | +12.83% |
Rolling returns
| Period | Fund | Category average |
|---|---|---|
| 1 month | -- | -3.44% |
| 3 months | +8.97% | +1.95% |
| 6 months | +12.80% | +19.58% |
| 1 year | +14.37% | +17.08% |
| 3 years | +67.79% | +73.64% |
| 5 years | +83.33% | +91.32% |
Past performance is not indicative of future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.
Nippon India Pharma Gr — frequently asked questions
What is the NAV of Nippon India Pharma Gr?
The latest net asset value (NAV) of Nippon India Pharma Gr is ₹538.68 per unit, +0.01% over the previous trading day. NAV is declared by the AMC at the end of every business day.
What returns has Nippon India Pharma Gr delivered?
Nippon India Pharma Gr has returned +11.56% over the trailing 5 years (1 year: +5.59%, 3 years: +15.41%). Returns beyond one year are annualised. Past performance does not guarantee future returns.
What is the expense ratio of Nippon India Pharma Gr?
Nippon India Pharma Gr charges an expense ratio of 1.85% per annum. The expense ratio is deducted from the scheme's assets, so the NAV you see is already net of it.
How risky is Nippon India Pharma Gr?
SEBI's riskometer classifies Nippon India Pharma Gr as Very High Risk, which is typical for a Sector - Healthcare scheme. Match the scheme's risk level to your own risk tolerance and investment horizon before investing.
What is the minimum investment in Nippon India Pharma Gr?
You can start a SIP in Nippon India Pharma Gr from ₹100 per month, and the minimum lumpsum investment is ₹5,000.
Who manages Nippon India Pharma Gr?
Nippon India Pharma Gr is managed by Nippon India Mutual Fund, holds ₹9,479.08 Cr in assets under management and invests across 36 holdings. This page covers the regular plan with the growth option.
Scheme identifiers
- Fund house
- Nippon India Mutual Fund
- Scheme category
- Equity
- Scheme sub-category
- Sector - Healthcare
- Plan
- Regular plan
- Option
- Growth
- ISIN
- INF204K01968
- Scheme code
- FSGBR07192